Constrictive Pericarditis and Pleuropulmonary Disease Linked to Ergot Dopamine Agonist Therapy (Cabergoline) for Parkinson's Disease

Mayo Clinic Proceedings - Netherlands
doi 10.4065/74.4.371
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Degos’ Disease With Constrictive Pericarditis

Japanese Circulation Journal
2000English

Rationale for Use of Dopamine Agonists in Parkinson's Disease: Review of Ergot Derivatives

Canadian Journal of Neurological Sciences
MedicineNeurology
1999English

Pesticide Use Linked to Parkinson's Disease

Nature
Multidisciplinary
2000English

Effusive–Constrictive Pericarditis

New England Journal of Medicine
Medicine
2004English

Two Cases of Patients With Parkinson's Disease Developing Valvular Heart Disease While Taking Cabergoline

Clinical Neurology
Neurology
2008English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

Constrictive Pericarditis – A Challenging Diagnosis

Case Reports in Internal Medicine
2017English

Dopamine-Derived Biological Reactive Intermediates and Protein Modifications: Implications for Parkinson's Disease

Chemico-Biological Interactions
MedicineToxicology
2011English

Inflammation: Role in Parkinson's Disease and Target for Therapy

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy